Estimation of Alprazolam and Sertraline in Pure Powder and Tablet Formulations by High-Performance Liquid Chromatography and High-Performance Thin-Layer Chromatography

Abstract

This article describes validated high-performance liquid chromatographic (HPLC) and high-performance thin-layer chromatographic (HPTLC) methods for simultaneous estimation of alprazolam (ALZ) and sertraline (SER) in pure powder and tablet formulation. The HPLC separation was achieved on a Nucleosil C18 column (150 mm long, 4.6 mm i.d., and 5-µm particle size) using acetonitrile and phosphate buffer (50 + 50 v/v), pH 5.5, as the mobile phase at a flow rate of 1.0 mL/min at ambient temperature. The HPTLC separation was achieved on an aluminum-backed layer of silica gel 60 F₂₅₄ using acetone/toluene/ammonia (6.0:3.0:1.0, v/v/v) as the mobile phase. Quantification with the HPLC method was achieved with ultraviolet (UV) detection at 230 nm over the concentration range 3–18 µg/mL for both drugs with mean recovery of 101.86 ± 0.21 and 100.57 ± 0.31% for ALZ and SER, respectively. Quantification in HPTLC was achieved with UV detection at 230 nm over the concentration range of 400–1400 ng/spot for both drugs with mean recoveries of 101.32 ± 0.15 and 100.38 ± 0.51% for ALZ and SER, respectively. These methods are rapid, simple, precise, sensitive, and are applicable for the simultaneous determination of ALZ and SER in pure powder and formulations.     

Speciation Analysis of Osmium(VIII) and Osmium(IV) by UV‐VIS Spectrophotometry Using Quercetin as the Reagent

Abstract

The UV‐VIS spectrophotometric methods for the determination of Os(VIII) (as OsO₄) and Os(IV) (as OsCl₆ ^2? complex) in their mixtures were developed. Quercetin (Q), a flavonoid compound, was used as a chromogenic reagent. Both direct and derivative spectrophotometry can be employed for the determination of Os(VIII). The calculation of the first‐derivative spectrum of the examined mixture and the use of the signal at 285.1 nm allows reaching a better detection limit (0.01 µg mL^?1 Os) as compared with direct spectrophotometry (0.1 µg mL^?1 Os). Relative standard deviations of the results are in the range of 0.87%–4.65% and 0.45%–1.15% for direct and derivative mode, respectively. Selective redox reaction of OsO₄ with Q under the conditions used (0.05 M HCl, 1×10^?4 M Q, 15 min heating at 70°C) makes the basis of its determination in mixtures with the OsCl₆ ^2? complex. Quercetin does not react with the OsCl₆ ^2? complex. The signals of the OsCl₆ ^2? complex can be isolated from the examined mixtures by the calculation of the third‐order derivative spectra and the use of the values at 340.0 nm. The effectiveness of the reduction of OsO₄ in chloride solutions has been studied by the developed method.     

Quantitative Determination of Nadolol in Tablets by High‐Performance Liquid Chromatography and UV‐Derivative Spectrophotometry

Abstract

High‐performance liquid chromatographic (HPLC) and UV derivative spectrophotometric (UVDS) methods were developed and validated for the quantitative determination of nadolol in tablets. The HPLC method was performed on a C18 column with fluorescence detection. The excitation and emission wavelengths were 230 and 300 nm, respectively. A mobile phase composed by acetonitrile‐water containing 0.1% triethylamine (15∶85 v/v) and pH adjusted to 4.6 with formic acid was used. The UVDS method was performed taken a signal at 279.5 nm. The correlation coefficient (r) obtained for both methods was 0.9999. The proposed methods are simple, precise, accurate, and can be used in routine analysis.     

Chromatographic methods development,validation and degradation characterization of the antithyroid drug Carbimazole

The current paper reports the development and validation of stability‐indicating HPLC and HPTLC methods for the separation and quantification of main impurity and degradation product of Carbimazole. The structures of the degradation products formed under stress degradation conditions, including hydrolytic and oxidative, photolytic and thermal conditions, were characterized and confirmed by MS and IR analyses. Based on the characterization data, the obtained degradation product from hydrolytic conditions was found to be methimazole—impurity A of Carbimazole as reported by the British Pharmacopeia and the European Pharmacopeia. A stability‐indicating HPLC method was carried out using a Zorbax Eclipse Plus CN column (150 × 4.6 mm i.d, 5 μm particle size) and a mobile phase composed of acetonitrile–0.05 m KH₂PO₄ (20: 80, v/v) in isocratic elution, at a flow rate of 1 mL/min. The method was proved to be sensitive for the determination down to 0.5% of Carbimazole impurity A. Additionally, a stability‐indicating chromatographic HPTLC method was achieved using cyclohexane–ethanol (9:1, v/v) as a developing system on HPTLC plates F₂₅₄ with UV detection at 225 nm. The proposed HPLC and HPTLC methods were successfully applied to Carbimazole^® tablets with mean percentage recoveries of 100.12 and 99.73%, respectively.     

Simultaneous Determination of Cadmium,Copper, Lead and Zinc in Amino Acid Parenteral Nutrition Solutions by Anodic Stripping Voltammetry and Sample Digestion by UV Irradiation

Abstract

Irradiation with ultraviolet (UV) energy was investigated to assay cadmium, copper, lead, and zinc by anodic stripping voltammetry (ASV) in amino acid parenteral nutrition (PN) solutions. Sample digestion by UV irradiation showed the best performances to liberate the metals from the samples (metal recoveries between 90% and 102%) in comparison with classical oxidative wet digestion methods. The best UV digestion condition was obtained with 1:10 diluted PN samples irradiated during 10 h at 90±3°C with the addition of one aliquot of 50 µL concentrated H₂SO₄ and repeated additions of 50 µL 30% (v/v) H₂O₂ at each 60 min irradiation interval. By using the UV digestion procedure cadmium, copper, lead, and zinc were simultaneously assayed in commercial amino acid PN solutions by ASV. The metal concentrations ranged between 1.3 to 4.4 for cadmium, 2.9 to 40.8 for copper, 4.4 to 16.8 for lead, and 1.4 to 208.5 for zinc. The ASV method correlated well with atomic absorption spectrometry measurements to assay the investigated analytes in amino acid PN samples after the UV digestion.     

Validated HPLC and HPTLC Method for Simultaneous Quantitation of Amlodipine Besylate and Olmesartan Medoxomil in Bulk Drug and Formulation

Two methods are described for simultaneous determination of amlodipine besylate and olmesartan medoxomil in formulation. The first method was based on the HPTLC separation of two drugs on Merck HPTLC aluminium sheets of silica gel 60 F₂₅₄ using n-butanol: acetic acid: water (5:1:0.1, v/v/v) as the mobile phase. The second method was based on the HPLC separation of the two drugs on the RP-PerfectSil-100 ODS-3–C₁₈ column from MZ-Analysetechnik GmbH, Germany and acetonitrile/0.03 M ammonium acetate buffer (pH = 3) in a ratio of 55:45 as the mobile phase. Both methods have been applied to formulation without interference of excipients of formulation.     

Liquid Chromatographic Method with Ultraviolet Absorbance Detection for Measurement of Rimonabant in Human Plasma

Abstract

Rimonabant is a selective cannabinoid CB1 receptor antagonist licensed in Europe for treatment of obesity when a risk factor is associated. The objective of this study was to develop and validate a method for measurement of rimonabant in human plasma using high-performance liquid chromatography coupled to an ultraviolet (UV) detector. Rimonabant and loxapine (internal standard) were extracted from 500 µL of plasma. Chromatography was performed on a 250 mm × 4.6 mm C18 column using a mobile phase constituted of 0.05 M ammonium acetate/methanol (25:75, v/v) at a flow rate of 1 ml/min followed by UV detection at 250 nm. Calibration curves covered a range from 13 (lower limit of quantification) to 1000.0 ng/mL. Validation results demonstrated that rimonabant could be accurately and precisely quantified in human plasma. Limit of quantification was 13 ng/mL. This simple method can be used for measuring rimonabant concentrations in human plasma in clinical practice.     

Two new heteroleptic ruthenium(II) dithiocarbamates: synthesis,characterization, DFT calculation and DNA binding

Two ruthenium(II) dithiocarbamates, cis-[Ru(DMP)₂L](BF₄), where L = 4-(4-methoxy-phenyl)piperazine-1-carbodithioate (1) and 4-(3-methoxyphenyl)piperazine-1-carbodithioate (2) and DMP = 2,9-dimethyl-1,10-phenanthroline, have been synthesized and characterized. The DNA-binding affinity of these metal complexes was investigated by UV–visible spectrophotometry with DNA-binding constants of 6.2 × 10⁴ M^?1 (1) and 1.2 × 10⁵ M^?1 (2) and electrostatic binding mode was confirmed by viscometric measurements. For insight into the structural differences, both complexes were studied computationally. B3LYP/LANL2DZ level of Density Functional Theory was used for the computational studies in Gaussian 09. The optimized bond lengths are in agreement with the reported values. Comparative computational studies reveal interesting transformations in bond lengths, angles, Natural Bond Orbital charges, molecular orbitals, Molecular Electro Static Potentials, and global chemical reactivity indices. Based on quantum chemical results a structure–activity relationship has been attempted.     

Simultaneous Separation and Determination of Lamivudine and Zidovudine in Pharmaceutical Formulations Using the HPTLC Method

Abstract

A high-performance thin-layer chromatographic method (HPTLC) for the simultaneous determination of lamivudine and zidovudine in a binary mixture has been developed. The method developed was based on HPTLC separation of the two drugs followed by densitometric measurements of spots at 276 and 271 nm for lamivudine and zidovudine, respectively. Separation was carried out on Merck HPTLC silica-gel 60 F₂₅₄ plates, using toluene/chloroform/methanol (1:6:3 v:v) as the mobile phase. Validation of the method was performed based on The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines in terms of linearity, accuracy, precision, limit of detection, limit of quantification, and robustness. Second-order polynomial equations were obtained for the regression line in the ranges of 250–1400 and 250–1700 ng/spot for lamivudine and zidovudine respectively. Correlation coefficient (r) values were 0.9998 for both analytes. The method provides sufficient accuracy as indicated by recovery percentages given for lamivudine and zidovudine. For system precision study, the low coefficient of variation values (<2%) for both lamivudine and zidovudine ensured reproducible performance of the instrument. In the method precision study, coefficients of variation <2% were obtained, which showed that the proposed method provides acceptable intraday and interday variation. The detection and quantification limits and were 3.06 and 9.28 ng/spot for lamivudine and 3.34 and 10.13 ng/spot for zidovudine, respectively. Parameters such as mobile-phase composition, volume of mobile phase, time from spotting to development, and time from development to scanning were employed while testing for robustness of the method, and the standard deviation of peak areas was calculated for each parameter. The low coefficient of variation values indicated the robustness of the method. Statistical manipulation did not show any significant effect of one parameter over the others on the robustness of the method.     

Acid-Catalyzed Hydrolysis of Some N,N-Dibenzylalkanesulfinamides in 50% Acetonitrile–Water

Abstract

The hydrolysis of some N,N-dibenzylalkanesulfinamides (RSONH(CH₂Ph)₂; 1, R = Me; 2, R = ⁱPr; 3, R = ^tBu; 4, R = 1-adamantyl) has been studied in 50% (v:v) acetonitrile–water solutions of hydrobromic and hydrochloric acids, mainly at 44.8 °C, using ultraviolet (UV) spectrophotometry to determine pseudo first-order rate constants. The compounds were found to hydrolyze by concurrent bimolecular neutral, acid-catalyzed, and acid-dependent nucleophilic (halide ion) catalysis pathways. The last-named is predominant in reactions in HBr solutions, but in HCl solutions, the acid-catalyzed pathway is predominant. The results indicate that both steric and electronic effects are important in these reactions. There appears to be no mechanistic switchover in the series 1→4.     

High‐Performance Liquid Chromatographic Determination of Parecoxib in Human Plasma and Pharmaceutical Formulations

Abstract

A simple and sensitive RP‐HPLC method for the determination of parecoxib (PXB) in human plasma and pharmaceutical formulations has been developed and validated. The separation of PXB and the internal standard, ibuprofen (IBF) was achieved on a CLC C₁₈ (5 μ, 25 cm×4.6 mm i.d.) column using UV detector at 200 nm. The mobile phase consisted of acetonitrile‐water (92:8 v/v). The linear range of detection was found to be 0.9–18.4 µg/ml (r=0.9985). Intra‐ and inter‐day assay relative standard deviations were observed to be less than 0.3%. The method has been applied successfully for the determination of PXB in spiked human plasma and pharmaceutical preparations. Analytical parameters were calculated and complete statistical evaluation is incorporated.     

A new copper(I) coordination polymer from 2,6-bis(1H-benzotriazol-1-ylmethyl)pyridine: Synthesis,characterization, and use as additive in transparent submicron UV filters

The use of a new copper(I) coordination polymer (CP) as additive in transparent composite films of 190 nm of thickness for ultraviolet (UV) shielding is presented. The luminescent 1-D Cu(I) CP was easily synthesized through a self-assembly process between Cu(I) iodide and 2,6-bis(1H-benzotriazol-1-ylmethyl)pyridine (L). The CP, [Cu₂(μ ? I)₂(μ ? L)₂]_n, was structurally characterized by infrared, UV–visible diffuse reflectance and photoluminescence spectroscopy, elemental and thermogravimetric analyses, single-crystal and powder X-ray diffraction, and relativistic density functional theory calculations. The CP was dispersed and immobilized into a polymeric matrix in the presence of Sudan I, yielding a composite material that exhibits a reduction of 49% of the UV transmittance at 350 nm. Thus, the use of a new Cu(I) CP in polymeric composite films appears as a novel approach toward ultrathin and transparent UV shielding films, which have potential applications as protection layers of paints and coatings that tend to degrade when exposed to UV radiation.     

Development and Validation of High Performance Liquid Chromatographic and UV-Derivative Spectrophotometric Methods for the Determination of Sotalol Hydrochloride in Tablets

Abstract

High performance liquid chromatographic (HPLC) and UV derivative spectrophotometric (UVDS) methods were developed and validated for the quantitative determination of sotalol hydrochloride in tablets. The HPLC method was performed on a C18 column with fluorescence detection. The excitation and emission wavelengths were 235 and 310 nm, respectively. The mobile phase was composed of acetonitrile-water containing 0.1% trietylamine (7:93 v/v) and pH adjusted to 4.6 with formic acid. The UVDS method was performed taking a signal at 239.1 nm in the first derivative. The correlation coefficients (r) obtained were 0.9998 and 0.9997 for HPLC and UVDS methods, respectively. The proposed methods are simple and adaptable to routine analysis.     

Interactions of nitrogen-donor bio-molecules with dinuclear platinum(II) complexes

Substitution reactions of the dinuclear Pt(II) complexes, [{Pt(en)Cl}₂(μ-pz)]²⁺ (1), [{Pt(dach)Cl}₂(μ-pz)]²⁺ (2) and [{Pt(dach)Cl}₂(μ-4,4?-bipy)]²⁺ (3), and corresponding aqua analogs with selected biologically important ligands, viz. 1,2,4-triazole, L-histidine (L-His) and guanosine-5?-monophosphate (5?-GMP) were studied under pseudo-first-order conditions as a function of concentration and temperature using UV–vis spectrophotometry. The reactions of the chloride complexes were followed in aqueous 25 mmol L^?1 Hepes buffer in the presence of 40 mmol L^?1 NaCl at pH 7.2, whereas the reactions of the aqua complexes were studied at pH 2.5. Two consecutive reaction steps, which both depend on the nucleophile concentration, were observed in all cases. The second-order rate constants for both reaction steps indicate a decrease in the order 1 > 2 > 3 for all complexes. Also, the pK_a values of all three aqua complexes were determined. The order of the reactivity of the studied ligands is 1,2,4-triazole > L-His > 5?-GMP. ¹H NMR spectroscopy and HPLC were used to follow the substitution of chloride in the dichloride 1, 2, and 3 complexes by guanosine-5?-monophosphate (5?-GMP). This study shows that the inert and bridging ligands have an important influence on the reactivity of the studied complexes.     

Development of Validated Chromatographic Methods for the Simultaneous Determination of Metronidazole and Spiramycin in Tablets

Two chromatographic methods have been described for the simultaneous determination of metronidazole (MET) and spiramycin (SPY) in their mixtures. The first method was based on a high performance thin layer chromatographic (HPTLC) separation of the two drugs followed by densitometric measurements of their spots at 240 nm. The separation was carried out on Merck TLC aluminum sheets of silica gel 60 F₂₅₄ using methanol: chloroform (9:1, v/v) as a mobile phase. Analysis data was used for the linear regression line in the range of 1.0–2.0 and 0.8–2.0 μg band⁻¹ for MET and SPY, respectively. The second method was based on a reversed-phase liquid chromatographic separation of the cited drugs on a C-18 column (5 μm, 250 × 4.6 mm, i.d.). The mobile phase consisted of a mixture of phosphate buffer of pH 2.4 and acetonitrile (70:30, v/v). The separation was carried out at ambient temperature with a flow rate of 1.0 mL min⁻¹. Quantitation was achieved with UV detection at 232 nm based on peak area with linear calibration curves at concentration ranges 0.4–50.0 and 0.5–50.0 μg mL⁻¹ for MET and SPY, respectively. The proposed chromatographic methods were successfully applied to the determination of the investigated drugs in pharmaceutical preparations. Both methods were validated in compliance with ICH guidelines; in terms of linearity, accuracy, precision, robustness, limits of detection and quantitation and other aspects of analytical validation.

     

Solubility of Icariin in a Binary Solvent System of Ethanol and Water

The solubility of icariin in the binary solvent system of ethanol and water was measured by UV–Vis spectrophotometry from 288.2 to 328.2 K. The solubility of icariin in the system increased with increasing temperature. A synergistic effect appeared at x ₂ = 0.4 (equivalent to 68.34 % ethanol, v/v) binary mixture. Solubility data were correlated with the modified Apelblat equation. The enthalpy and entropy of solution were evaluated using van’t Hoff plots.     

Determination of Mycophenolic Acid (MPA) and Its Acyl and Phenol Glucuronide Metabolits Simultaneously in Human Plasma by a Simplified HPLC Method

Abstract

A simple HPLC method with ultraviolet detection for simultaneous determination of Mycophenolic acid (MPA), its phenol glucuronide metabolite (MPAG) and acyl‐MPAG (AcMPAG) in human plasma was established. The plasma samples were prepared with protein‐preciptaing reagent, and the supernatant was eluted on Zorbax column (250 mm×4.6 mm i.d, 5 µm) with 20 mmol/l NaH₂PO₄ buffer (pH 3.0, adjusted with 20% phosphoric acid) and methanol (45:55, v/v) at 304 nm. The column temperature was 45°C, and the flow rate was 1.2 ml/min. The assay was linear within the range of 0.2–50 µg/L for MPA (r=0.9997), 2.8–531 µg/L for MPAG (r=0.9999), and 0.3–24 µg/L for AcMPAG (r=0.9994). Mean absolute recovery of MPA and its metabolites and internal standard was >80%. The average recoveries of MPA, MPAG, and AcMPAG were 94.0–101.4, 98.4–101.9, and 96.1–104.2%, respectively. The RSD of within‐day and between‐day were all lower than 15%. The method described is sensitive, reproducible, and will be useful in TDM or pharmacokinetic studies of MPA.     

Aqua substitution from mononuclear Pt(II) complexes with 2-(pyrazol-1-ylmethyl)quinoline non-leaving ligands

The rates of aqua substitution from [Pt{2-(pyrazol-1-ylmethyl)quinoline}(H₂O)₂](ClO₄)₂, [Pt(H₂Qn)], [Pt{2-(3,5-dimethylpyrazol-1-ylmethyl)quinoline}(H₂O)₂](ClO₄)₂, [Pt(dCH₃Qn)], [Pt{2-[(3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]quinoline}(H₂O)₂](ClO₄)₂, [Pt(dCF₃Qn)], and [Pt{2-[(3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]pyridine}(H₂O)₂](ClO₄)₂, [Pt(dCF₃Py)], with three sulfur donor nucleophiles were studied. The reactions were followed under pseudo-first-order conditions as a function of nucleophile concentration and temperature using a stopped-flow analyzer and UV/visible spectrophotometry. The substitution reactions proceeded sequentially. The second-order rate constants for substituting the aqua ligands in the first substitution step increased in the order Pt(dCH₃Qn) < Pt(dCF₃Qn) < Pt(H₂Qn) < Pt(dCF₃Py), while that of the second substitution step was Pt(dCH₃Qn) < Pt(dCF₃Qn) < Pt(dCF₃Py) < Pt(H₂Qn). The reactivity trends confirm that the quinoline substructure in the (pyrazolylmethyl)quinoline ligands acts as an apparent donor of electron density toward the metal center rather than being a π-acceptor. Measured pK_a values from spectrophotometric acid–base titrations were Pt(H₂Qn) (pK_a1 = 4.56; pK_a2 = 6.32), Pt(dCH₃Qn) (pK_a1 = 4.88; pK_a2 = 6.31), Pt(dCF₃Qn) (pK_a1 = 4.07; pK_a2 = 6.35), and Pt(dCF₃Py) (pK_a1 = 4.76; pK_a2 = 6.27). The activation parameters from the temperature dependence of the second-order rate constants support an associative mechanism of substitution.     

Co−MOFs with 1,1′-(5-methyl-1,3-phenylene)bis(1H-imidazole) and aromatic carboxylates as coligands: synthesis,structure, and spectroscopic and thermal characterizations

Four cobalt(II) compounds, [Co(Bim)(IA)(H₂O)₂]_n·0.5nH₂O (1), [Co(Bim)(MA)(H₂O)₂]_n (2), [Co₂(Bim)₂(MA)₂]_n·nH₂O (3), and [Co₃(Bim)₄(TA)₂(H₂O)₂]_n·2.5nH₂O (4), have been synthesized by solvothermal reactions of cobalt(II) salts with 1,1′-(5-methyl-1,3-phenylene)bis(1H-imidazole) [Bim] and aromatic polycarboxylic acids (H₂IA = isophthalic acid, H₂MA = 5-methylisophthalic acid, and H₃TA = trimesic acid) as coligands. The four complexes were characterized by IR and UV?vis spectra, elemental analyses, X-ray powder and single-crystal diffractions, and thermogravimetric analyses (TGAs). 1 features a zigzag polymeric macrocycle chain containing a nanotubular channel, which is constructed by bridging the folded 20-membered macrocyclic [Co₂(Bim)₂] subunits with IA ligands. 2 represents a double-chain structure containing 18-membered macrocyclic [Co₂(Bim)(MA)] subunits. Both 3 and 4 are 2-D porous coordination polymers but have different architectures. In 3, cage-like [Co₄(Bim)₂(MA)₄] subunits are 4-connected nodes that are further bridged by another half-set of Bim ligands to form a 2-D helical structure containing one-dimensional achiral channels and alternately arranged left- and right-handed helical tubular channels. In 4, Bim ligands bridge three crystallographically independent Co centers into sharply distorted left- and right-handed helices which are further connected by TA ligands to form a meso layer about 3.0 nm monolayer thickness with a unique (3,4)-connected topology. The structural diversities of coordination polymers 1–4 are tuned by the flexible coordination number of Co and coligand polycarboxylates. Thermal analyses show that the main frameworks of all compounds remain stable to 352 °C. Moreover, the interesting color changes of crystals 1–4, varying from pink to purple and dark blue, result from the d → d* transitions of chromophoric Co²⁺ in different coordination geometries as determined by the UV–vis spectra in combination with crystal structure analyses.     

Tricarbonylrhenium(I) complexes with the N,6-dimethylpyridine-2-carbothioamide ligand: combined experimental and calculation studies

Abstract

A new series of tricarbonyl complexes of rhenium(I) in the “2 + 1” system with the bidentate ligand N,6-dimethylpyridine-2-carbothioamide ((CH₃)NC₅H₄-CS-NH-CH₃, MeLH(Me)_NS) and a monodentate ligand (halides Cl, Br, or I, and the pseudohalide NCS anion) was synthesized. The use of mixed ligands led to the formation of neutral tricarbonylrhenium(I) complexes [Re(CO)₃(MeLH(Me)_NS)X] (X = Cl, Br, I, NCS) (1–4). Single-crystal X-ray diffraction was used to determine the crystal structures of all four compounds and those results were compared with molecular structures obtained from DFT calculations using the PBE0/def2-TZVPD approach. The complexes were also characterized by spectroscopic (FT-IR, NMR, and UV–vis) and analytical (HPLC, TGA, EA, ESI-MS) techniques. IR and UV–vis spectra were also calculated by DFT and TD-DFT methods. The cytotoxicity of these complexes was estimated using human ovarian cancer cell lines (A2780 and A2780cis), cervical cancer cells (HeLa), and non-cancerous human embryonic kidney cells (Hek-293). The toxicity of most complexes was moderate or low toward cancer cell lines (IC₅₀ = 46–231 μM) and similar against non-cancerous cells (IC₅₀ = 41-121 μM). Only the complex with chlorido ligand remarkably inhibited growth of ovarian cancer cells (IC₅₀ = 3 and 12 μM for A2780 and A2780cis, respectively). The cytotoxicity of 1 was higher than that of cisplatin.